• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cosmos Health Inc. - Common Stock (NQ:COSM)

0.3899 -0.0081 (-2.04%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cosmos Health Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board
February 24, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value
February 19, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Continues UK Retail Expansion for C-Scrub; Now Available at Superdrug, the UK’s Second-Largest Beauty and Health Retailer
February 18, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Announces Growing Momentum for C-Scrub in the United Kingdom; Now Available at Tesco, the UK’s Largest Retailer
February 18, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026
February 17, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies
February 11, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue
January 20, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Announces Initiation of Analyst Coverage with $4.50 Valuation by Zacks Small-Cap Research
January 14, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units
January 05, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy
December 24, 2025
Via ACCESS Newswire
News headline image
Cosmos Health is Forcing the Market to Reframe the Conversation
December 19, 2025
Via ACCESS Newswire
News headline image
Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets
December 03, 2025
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases
December 02, 2025
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M
November 17, 2025
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy
October 31, 2025
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million
October 21, 2025
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Requirement
October 16, 2025
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million
October 13, 2025
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility
October 10, 2025
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
October 06, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
October 03, 2025
 
Via Benzinga
News headline image
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
October 03, 2025
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
News headline image
Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units
October 03, 2025
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation
September 29, 2025
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL® Pessaries Annually
September 25, 2025
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue
September 22, 2025
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
September 12, 2025
 
Via Benzinga
News headline image
Keep an eye on the top gainers and losers in Friday's session. ↗
September 12, 2025
Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
September 11, 2025
 
Via Benzinga
News headline image
Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units
September 11, 2025
From Cosmos Health Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap